Treatt Q1 revenues in line with expectations, Q2 starts 'well'

Treatt
444.00p
16:45 19/02/25
Natural extracts and ingredients business Treatt said on Thursday that Q1 revenues were in line with internal expectations and that Q2 had "started well".
Chemicals
7,064.56
16:49 19/02/25
FTSE All-Share
4,721.15
17:14 19/02/25
FTSE Small Cap
6,779.86
17:14 19/02/25
Treatt said it was encouraged by a "robust pipeline and order intake". It also noted cash generation continued to be a focus and remains in line with management expectations for the full year.
In its Heritage unit, Treatt said it continued to leverage its deep knowledge and product capabilities to provide solutions against a market backdrop of continued high orange oil prices, and also said it remains focussed on growing higher margin Premium volumes, stating it was "well placed" with opportunities with both new and existing customers.
In its New Markets division, Treatt's China business continued to "progress well" ahead of the opening of its Shanghai Innovation Centre later in FY25.
As of 1020 GMT, Treatt shares were down 0.017% at 429.92p.
Reporting by Iain Gilbert at Sharecast.com